Variations in TAP1 and PSMB9 Genes Involved in Antigen Processing and Presentation Increase the Risk of Vitiligo in the Saudi Community

References

• Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51(10):1206–1212. doi:10.1111/j.1365-4632.2011.05377.x
   PubMed Web of Science ®Google Scholar
• Mosher DB, Fitzpatrick TB, Ortanne JB. Disorders of pigmentation, hipomelanoses and hypermelanoses. In: Freedberg IM, Eisen AZ, Fitzpatrick TB, eds. Dermatology in General Medicine. New York, NY: McGraw-Hill; 1999:936–945.
   Google Scholar
• Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65(3):473–491. doi:10.1016/j.jaad.2010.11.061
   PubMed Web of Science ®Google Scholar
• Boisseau-Garsaud AM, Garsaud P, Cales-Quist D, Helenon R, Queneherve C, Claire RC. Epidemiology of vitiligo in the French West Indies (Isle of Martinique). Int J Dermatol. 2000;39(1):18–20. doi:10.1046/j.1365-4362.2000.00880.x
   PubMed Web of Science ®Google Scholar
• Stromberg S, Bjorklund MG, Asplund A, et al. Transcriptional profiling of melanocytes from patients with vitiligo vulgaris. Pigment Cell Melanoma Res. 2008;21(2):162–171. doi:10.1111/j.1755-148X.2007.00429
   PubMed Web of Science ®Google Scholar
• Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386(9988):74–84. doi:10.1016/S0140-6736(14)60763-7
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cai Y, Shi M, et al. The prevalence of vitiligo: a meta-analysis. PLoS One. 2016;11(9):e0163806. doi:10.1371/journal.pone.0163806
   PubMed Web of Science ®Google Scholar
• Gianfaldoni S, Wollina U, Tchernev G, Lotti J, Franca K, Lotti T. Vitiligo in children: a review of conventional treatments. Open Access Maced J Med Sci. 2018;6(1):213–217. doi:10.3889/oamjms.2018.054
   PubMedGoogle Scholar
• Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020;236(6):571–592. doi:10.1159/000506103
   PubMed Web of Science ®Google Scholar
• van den Boorn JG, Konijnenberg D, Dellemijn TA, et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol. 2009;129(9):2220–2232. doi:10.1038/jid.2009.32
   PubMed Web of Science ®Google Scholar
• Richmond JM, Strassner JP, Zapata L Jr, et al. Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo. Sci Transl Med. 2018;10(450). doi:10.1126/scitranslmed.aam7710
   PubMed Web of Science ®Google Scholar
• Singh M, Mansuri MS, Jadeja SD, Marfatia YS, Begum R. Association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism with vitiligo susceptibility in Gujarat population. Indian J Dermatol Venereol Leprol. 2018;84(3):285–291. doi:10.4103/ijdvl.IJDVL_1_17
   PubMed Web of Science ®Google Scholar
• Jarallah JS, Al-Sheikh OA, El-Shabrawy M, Al-Wakeel MA. Vitiligo: epidemiology and clinical pattern at King Khalid University Hospital. Ann Saudi Med. 1993;13(4):332–334. doi:10.5144/0256-4947.1993.332
   PubMed Web of Science ®Google Scholar
• Shelleh HH, Al-Hatiti HS. Pattern of skin diseases in a hospital in southwestern Saudi Arabia. Saudi Med J. 2004;25(4):507–510.
   PubMed Web of Science ®Google Scholar
• Alakloby OM. Pattern of skin diseases in Eastern Saudi Arabia. Saudi Med J. 2005;26(10):1607–1610.
   PubMed Web of Science ®Google Scholar
• Al-Saeed WY, Al-Dawood KM, Bukhari IA, Bahnassy AA. Prevalence and pattern of skin disorders among female schoolchildren in Eastern Saudi Arabia. Saudi Med J. 2006;27(2):227–234.
   PubMed Web of Science ®Google Scholar
• Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003;16(3):208–214. doi:10.1034/j.1600-0749.2003.00032.x
   PubMedGoogle Scholar
• Shajil EM, Chatterjee S, Agrawal D, Bagchi T, Begum R. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes. Ind J Exp Biol. 2006;44:52639.
   Google Scholar
• Laddha NC, Dwivedi M, Mansuri MS, et al. Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility. PLoS One. 2014;9(9):e107020. doi:10.1371/journal.pone.0107020
   PubMed Web of Science ®Google Scholar
• Praest P, Luteijn RD, Brak-Boer IGJ, et al. The influence of TAP1 and TAP2 gene polymorphisms on TAP function and its inhibition by viral immune evasion proteins. Mol Immunol. 2018;101:55–64. doi:10.1016/j.molimm.2018.05.025
   PubMed Web of Science ®Google Scholar
• Powis SH, Tonks S, Mockridge I, Kelly AP, Bodmer JG, Trowsdale J. Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics. 1993;37(5):373–380. doi:10.1007/BF00216802
   PubMed Web of Science ®Google Scholar
• Polvi A, Maki M, Partanen J. Celiac patients predominantly inherit HLA-DPB1*0101 positive haplotype from HLA-DQ2 homozygous parent. Hum Immunol. 1997;53(2):156–158. doi:10.1016/S0198-8859(97)00027-X
   PubMed Web of Science ®Google Scholar
• Kostik MM, Klyushina AA, Moskalenko MV, Scheplyagina LA, Larionova VI. Glucocorticoid receptor gene polymorphism and juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2011;9(1):2. doi:10.1186/1546-0096-9-2
   PubMed Web of Science ®Google Scholar
• Sainaghi PP, Collimedaglia L, Alciato F, et al. Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis. Mediators Inflamm. 2013;2013:406483. doi:10.1155/2013/406483
   PubMed Web of Science ®Google Scholar
• Sheth VM, Guo Y, Qureshi AA. Comorbidities associated with vitiligo: a ten-year retrospective study. Dermatology. 2013;227(4):311–315. doi:10.1159/000354607
   PubMed Web of Science ®Google Scholar
• Colucci R, Lotti F, Dragoni F, et al. High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. Br J Dermatol. 2014;171(4):786–798. doi:10.1111/bjd.13286
   PubMed Web of Science ®Google Scholar
• Kivity S, Arango MT, Ehrenfeld M, et al. Infection and autoimmunity in Sjogren’s syndrome: a clinical study and comprehensive review. J Autoimmun. 2014;51:17–22. doi:10.1016/j.jaut.2014.02.008
   PubMed Web of Science ®Google Scholar
• Kronenberg-Versteeg D, Eichmann M, Russell MA, et al. Molecular pathways for immune recognition of preproinsulin signal peptide in type 1 diabetes. Diabetes. 2018;67(4):687–696. doi:10.2337/db17-0021
   PubMed Web of Science ®Google Scholar
• Djilali-Saiah I, Caillat-Zucman S, Schmitz J, Chaves-Vieira ML, Bach JF. Polymorphism of antigen processing (TAP, LMP) and HLA class II genes in celiac disease. Hum Immunol. 1994;40(1):8–16. doi:10.1016/0198-8859(94)90015-9
   PubMed Web of Science ®Google Scholar
• Teisserenc H, Schmitt W, Blake N, et al. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway. Immunol Lett. 1997;57(1–3):183–187. doi:10.1016/s0165-2478(97)00072-2
   PubMed Web of Science ®Google Scholar
• Casp CB, She JX, McCormack WT. Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo. Genes Immun. 2003;4(7):492–499. doi:10.1038/sj.gene.6364016
   PubMed Web of Science ®Google Scholar
• Kramer U, Illig T, Grune T, Krutmann J, Esser C. Strong associations of psoriasis with antigen processing LMP and transport genes TAP differ by gender and phenotype. Genes Immun. 2007;8(6):513–517. doi:10.1038/sj.gene.6364404
   PubMed Web of Science ®Google Scholar
• Singh A, Sharma P, Kar HK, et al. HLA alleles and amino-acid signatures of the peptide-binding pockets of HLA molecules in vitiligo. J Invest Dermatol. 2012;132(1):124–134. doi:10.1038/jid.2011.240
   PubMed Web of Science ®Google Scholar
• Birlea SA, Ahmad FJ, Uddin RM, et al. Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent. J Invest Dermatol. 2013;133(5):1369–1372. doi:10.1038/jid.2012.501
   PubMed Web of Science ®Google Scholar
• Jin Y, Andersen G, Yorgov D, et al. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat Genet. 2016;48(11):1418–1424. doi:10.1038/ng.3680
   PubMed Web of Science ®Google Scholar
• Dey-Rao R, Sinha AA. Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets. BMC Genomics. 2017;18(1):109. doi:10.1186/s12864-017-3510-3
   PubMed Web of Science ®Google Scholar
• Frisoli ML, Essien K, Harris JE. Vitiligo: mechanisms of pathogenesis and treatment. Annu Rev Immunol. 2020;38:621–648. doi:10.1146/annurev-immunol-100919-023531
   PubMed Web of Science ®Google Scholar
• Zaiss DM, Bekker CP, Grone A, Lie BA, Sijts AJ. Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases. J Immunol. 2011;187(5):2302–2309. doi:10.4049/jimmunol.1101003
   PubMed Web of Science ®Google Scholar
• Kincaid EZ, Che JW, York I, et al. Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat Immunol. 2011;13(2):129–135. doi:10.1038/ni.2203
   PubMed Web of Science ®Google Scholar
• Basler M, Kirk CJ, Groettrup M. The immunoproteasome in antigen processing and other immunological functions. Curr Opin Immunol. 2013;25(1):74–80. doi:10.1016/j.coi.2012.11.004
   PubMed Web of Science ®Google Scholar
• Shelleh HH, Al-Hatiti HS. Pattern of skin diseases in a hospital in southwestern Saudi Arabia. Saudi Med J. 2004;25(4):507–510.
   PubMed Web of Science ®Google Scholar
• Assiri AA, Yousuf BI, Quantock AJ, Murphy PJ. Incidence and severity of keratoconus in Asir province, Saudi Arabia. Br J Ophthalmol. 2005;89(11):1403–1406. doi:10.1136/bjo.2005.074955
   PubMed Web of Science ®Google Scholar
• Abanmi A, Al Harthi F, Al Baqami R, et al. Association of HLA loci alleles and antigens in Saudi patients with vitiligo. Arch Dermatol Res. 2006;298(7):347–352. doi:10.1007/s00403-006-0699-4
   PubMed Web of Science ®Google Scholar
• Abanmi A, Al Harthi F, Zouman A, et al. Association of Interleukin-10 gene promoter polymorphisms in Saudi patients with vitiligo. Dis Markers. 2008;24(1):51–57. doi:10.1155/2008/210609
   PubMed Web of Science ®Google Scholar
• Alissa A, Al Eisa A, Huma R, Mulekar S. Vitiligo-epidemiological study of 4134 patients at the National Center for Vitiligo and Psoriasis in Central Saudi Arabia. Saudi Med J. 2011;32(12):1291–1296.
   PubMed Web of Science ®Google Scholar
• Al-Shobaili HA. Correlation of clinical efficacy and psychosocial impact on vitiligo patients by excimer laser treatment. Ann Saudi Med. 2014;34(2):115–121. doi:10.5144/0256-4947.2014.115
   PubMed Web of Science ®Google Scholar
• Al-Harthi F, Zouman A, Arfin M, Tariq M, Al-Asmari A. Tumor necrosis factor-alpha and -beta genetic polymorphisms as a risk factor in Saudi patients with vitiligo. Genet Mol Res. 2013;12(3):2196–2204. doi:10.4238/2013.July.8.1
   PubMed Web of Science ®Google Scholar
• Alenizi DA. Consanguinity pattern and heritability of vitiligo in Arar, Saudi Arabia. J Family Community Med. 2014;21(1):13–16. doi:10.4103/2230-8229.128767
   PubMedGoogle Scholar
• Al-Shobaili HA, Rasheed Z. Mitochondrial DNA acquires immunogenicity on exposure to nitrosative stress in patients with vitiligo. Hum Immunol. 2014;75(10):1053–1061. doi:10.1016/j.humimm.2014.09.003
   PubMed Web of Science ®Google Scholar
• Alzolibani AA, Al Robaee A, Al-Shobaili H, Al-Saif F, Al-Mekhadab E, Settin AA. Association of CYP2C9 genetic variants with vitiligo. Ann Dermatol. 2014;26(3):343–348. doi:10.5021/ad.2014.26.3.343
   PubMed Web of Science ®Google Scholar
• Tayeb MT. Genetic variations of vitiligo among Saudi patients. Middle East J Sci Res. 2011;7(3):266–271.
   Google Scholar
• Sindi IA, Babalghith AO, Tayeb MT, et al. Risk of colorectal carcinoma may predispose to the genetic variants of the GST, CYP450, and TP53 genes among nonsmokers in the Saudi community. Int J Gen Med. 2021;14:1311–1323. doi:10.2147/IJGM.S294802
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447–52. doi:10.1093/nar/gku1003
   PubMed Web of Science ®Google Scholar
• Jadeja SD, Mansuri MS, Singh M, Dwivedi M, Laddha NC, Begum R. A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat. PLoS One. 2017;12(7):e0180958. doi:10.1371/journal.pone.0180958
   PubMed Web of Science ®Google Scholar
• Dani P, Patnaik N, Singh A, et al. Association and expression of the antigen-processing gene PSMB8, coding for low-molecular-mass protease 7, with vitiligo in North India: case-control study. Br J Dermatol. 2018;178(2):482–491. doi:10.1111/bjd.15391
   PubMed Web of Science ®Google Scholar
• McHepange UO, Gao XH, Liu YY, et al. Vitiligo in North-Eastern China: an association between mucosal and acrofacial lesions. Acta Derm Venereol. 2010;90(2):136–140. doi:10.2340/00015555-0799
   PubMed Web of Science ®Google Scholar
• Uncu S, Yayli S, Bahadir S, Okten A, Alpay K. Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. Int J Dermatol. 2011;50(2):175–179. doi:10.1111/j.1365-4632.2010.04665.x
   PubMed Web of Science ®Google Scholar
• Vora RV, Patel BB, Chaudhary AH, Mehta MJ, Pilani AP. A clinical study of vitiligo in a rural set up of Gujarat. Indian J Community Med. 2014;39(3):143–146. doi:10.4103/0970-0218.137150
   PubMedGoogle Scholar
• Degboe B, Atadokpede F, Saka B, et al. Vitiligo on black skin: epidemiological and clinical aspects in dermatology, Cotonou (Benin). Int J Dermatol. 2017;56(1):92–96. doi:10.1111/ijd.13366
   PubMed Web of Science ®Google Scholar
• Mahajan VK, Vashist S, Chauhan PS, Mehta KIS, Sharma V, Sharma A. Clinico-epidemiological profile of patients with vitiligo: a retrospective study from a Tertiary Care Center of North India. Indian Dermatol Online J. 2019;10(1):38–44. doi:10.4103/idoj.IDOJ_124_18
   PubMedGoogle Scholar
• Sehgal VN, Srivastava G. Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol. 2007;73(3):149–156. doi:10.4103/0378-6323.32708
   PubMed Web of Science ®Google Scholar
• Ezzedine K, Diallo A, Leaute-Labreze C, et al. Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo. Br J Dermatol. 2012;167(3):490–495. doi:10.1111/j.1365-2133.2012.11002.x
   PubMed Web of Science ®Google Scholar
• Nicolaidou E, Antoniou C, Miniati A, et al. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics. J Am Acad Dermatol. 2012;66(6):954–958. doi:10.1016/j.jaad.2011.07.010
   PubMed Web of Science ®Google Scholar
• Gould IM, Gray RS, Urbaniak SJ, Elton RA, Duncan LJ. Vitiligo in diabetes mellitus. Br J Dermatol. 1985;113(2):153–155. doi:10.1111/j.1365-2133.1985.tb02057.x
   PubMed Web of Science ®Google Scholar
• Somorin AO, Krahn PM. Vitiligo: a study of 122 cases. Ann Saudi Med. 1997;17(1):125–127. doi:10.5144/0256-4947.1997.125
   PubMed Web of Science ®Google Scholar
• Arýcan O, Koc K, Ersoy L. Clinical characteristics in 113 Turkish vitiligo patients. Acta Dermatovenerol Alp Pannonica Adriat. 2008;17(3):129–132.
   PubMedGoogle Scholar
• Alkhateeb A, Al-Dain Marzouka N, Qarqaz F. SMOC2 gene variant and the risk of vitiligo in Jordanian Arabs. Eur J Dermatol. 2010;20(6):701–704. doi:10.1684/ejd.2010.1095
   PubMed Web of Science ®Google Scholar
• Vrijman C, Kroon MW, Limpens J, et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol. 2012;167(6):1224–1235. doi:10.1111/j.1365-2133.2012.11198.x
   PubMed Web of Science ®Google Scholar
• Shong YK, Kim JA. Vitiligo in autoimmune thyroid disease. Thyroidology. 1991;3(2):89–91.
   PubMedGoogle Scholar
• De Sanctis V, Khater D. Autoimmune diseases in Turner syndrome: an overview. Acta Biomed. 2019;90(3):341–344. doi:10.23750/abm.v90i3.8737
   PubMedGoogle Scholar
• Bittles AH, Black ML. Evolution in health and medicine Sackler colloquium: consanguinity, human evolution, and complex diseases. Proc Natl Acad Sci U S A. 2010;107(Suppl 1):1779–1786. doi:10.1073/pnas.0906079106
   PubMed Web of Science ®Google Scholar
• El-Mouzan MI, Al-Herbish AS, Al-Salloum AA, Qurachi MM, Al-Omar AA. Growth charts for Saudi children and adolescents. Saudi Med J. 2007;28(10):1555–1568.
   PubMed Web of Science ®Google Scholar
• Turnpenny P, Ellard S. Emery’s Elements of Medical Genetics. Vol. 269. 14th ed. Elsevier Churchill Livingstone; 2013
   Google Scholar
• Al Fahaad HA. Clinico-epidemiological profile of vitiligo patients in Najran region, Saudi Arabia. J Derm Dermatol Surgery. 2015;19(1):31–35. doi:10.1016/j.jdds.2014.05.001
   Google Scholar
• AlGhamdi KM. Beliefs and perceptions of Arab vitiligo patients regarding their condition. Int J Dermatol. 2010;49(10):1141–1145. doi:10.1111/j.1365-4632.2010.04514.x
   PubMed Web of Science ®Google Scholar
• Alharbi MA. Identifying patients at higher risk of depression among patients with vitiligo at outpatient setting. Mater Sociomed. 2020;32(2):108–111. doi:10.5455/msm.2020.32.108-111
   PubMedGoogle Scholar
• Alzolibani A. Genetic epidemiology and heritability of vitiligo in the Qassim region of Saudi Arabia. Acta Dermatovenerol Alp Pannonica Adriat. 2009;18(3):119–125.
   PubMedGoogle Scholar
• Seif Eldin NS, Teama S, Amro K, Farag HM, Nour Eldin SM, Elhawary NA. Polymorphisms of TAP1/LMP7 loci in Egyptian patients with vitiligo. Egy J Med Hum Genet. 2006;7(2):241–249.
   Google Scholar
• El-Husseiny R, Abd-Elhaleem A, Salah El-Din W, Abdallah M. Childhood vitiligo in Egypt: clinico-epidemiologic Profile of 483 patients. J Cosmet Dermatol. 2021;20(1):237–242. doi:10.1111/jocd.13451
   PubMed Web of Science ®Google Scholar
• Spritz RA. Modern vitiligo genetics sheds new light on an ancient disease. J Dermatol. 2013;40(5):310–318. doi:10.1111/1346-8138.12147
   PubMed Web of Science ®Google Scholar
• Czajkowski R, Mecinska-Jundzill K. Current aspects of vitiligo genetics. Postepy Dermatol Alergol. 2014;31(4):247–255. doi:10.5114/pdia.2014.43497
   PubMed Web of Science ®Google Scholar
• Shen C, Gao J, Sheng Y, et al. Genetic susceptibility to vitiligo: GWAS approaches for identifying vitiligo susceptibility genes and loci. Front Genet. 2016;7:3. doi:10.3389/fgene.2016.00003
   PubMed Web of Science ®Google Scholar
• Cheng L, Liang B, Tang XF, et al. Validation of susceptibility loci for vitiligo identified by GWAS in the Chinese Han population. Front Genet. 2020;11:542275. doi:10.3389/fgene.2020.542275
   PubMed Web of Science ®Google Scholar